Publication Date:
2021
abstract:
We report here the introduction of SARS-COV-2 C.37, a variant of interest (VOI) recently renamed "lambda" by WHO, from Peru to Italy. We discuss mutations of concern in this lineage, and evidences for impaired sensitivity to neutralizing antibody-therapeutics and vaccines.
Iris type:
Articolo su Rivista
Keywords:
20D; COVID-19; GR/452Q.V1; Lambda variant; SARS-COV-2 C.37; SARS-CoV-2; variant of interest
List of contributors:
Baj, Andreina; Novazzi, Federica; Ferrante, Francesca Drago; Genoni, Angelo; Cassani, Gianluca; Prestia, Martina; Colombo, Alberto; Capuano, Riccardo; Zago, Christian; Pasciuta, Renee; Tamborini, Antonio; Rossi, Agostino; Tettamanzi, Elena; Catanoso, Giuseppe; Focosi, Daniele; Maffioli, Lorenzo; Maggi, Fabrizio
Published in: